Abeona buys EoE drug candidate APT-1011, raises $30 million as ZEVASKYN sales growNov 9M&AAbeona Therapeutics, IncEupraxia Pharmaceuticals Inc.Updated
Abeona acquires EoE drug candidate ABO-801 from Ellodi, plans $30 million private placementNov 9M&AAbeona Therapeutics, Inc
Teva completes Phase 3 asthma inhaler trial; registers vitiligo program and five ANDA actionsNov 6Weekly roundup, 8 itemsalbuterolduvakitug
GSK posts Phase 3b results for Bexsero booster; registers new bioavailability and UC trialsNov 6Weekly roundup, 7 itemsaletekitugbepirovirsenUpdated
GSK discloses FDA hold on infant pneumococcal vaccine study; posts two Phase 3/4 resultsOct 9Weekly roundup, 9 itemsdostarlimab-gxlyGlaxoSmithKlineUpdated
Glenmark wins FDA approvals for fluticasone nasal spray, rosuvastatin label updateAug 18Weekly roundup, 2 itemsfluticasoneGlenmark Pharmaceuticals